Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)

被引:0
|
作者
Guanggai Xia
Hongcheng Wang
Ziliang Song
Qingcai Meng
Xiuyan Huang
Xinyu Huang
机构
[1] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of general surgery
[2] Fudan University Shanghai Cancer Center,Department of Pancreatic Surgery, Pancreatic Cancer Institute
关键词
Pancreatic cancer; Gemcitabine; Gambogic acid; RRM2;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Oxymatrine induces anti-tumor response in cervical cancer by modulating circ_0008460/miR-197-3p/ribonucleotide reductase subunit M2 (RRM2)
    Li, Siwei
    Zhang, Heng
    Jiao, Yunping
    Song, Xiao
    Wei, Lei
    Liu, Xing
    BIOENGINEERED, 2022, 13 (05) : 12912 - 12926
  • [32] RIBONUCLEOTIDE REDUCTASE SUBUNIT 2 (RRM2) PREDICTS SHORTER SURVIVAL IN RESECTED STAGE I-III NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Dal Bello, M. G.
    Savarino, G.
    Rijavec, E.
    Sini, C.
    Barletta, G.
    Genova, C.
    Truini, M.
    Merlo, D.
    Pfeffer, U.
    Grossi, F.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S30 - S30
  • [33] Ribonucleotide reductase subunit 2 (RRM2) predicts shorter survival in resected stage I-III non-small cell lung cancer (NSCLC) patients
    Grossi, F.
    Rijavec, E.
    Dal Bello, M. G.
    Savarino, G.
    Sini, C.
    Barletta, G.
    Genova, C.
    Truini, M.
    Pfeffer, U.
    Merlo, D. F.
    LUNG CANCER, 2012, 77 : S23 - S23
  • [34] RIBONUCLEOTIDE REDUCTASE SUBUNIT 2 (RRM2) PREDICTS SHORTER SURVIVAL IN RESECTED STAGE I-III NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Grossi, F.
    Barletta, G.
    Sini, C.
    Rijavec, E.
    Genova, C.
    Dal Bello, M. G.
    Savarino, G.
    Truini, M.
    Merlo, F.
    Pronzato, P.
    ANNALS OF ONCOLOGY, 2012, 23 : 79 - 79
  • [35] Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer
    Volante, Marco
    Terzolo, Massimo
    Fassnacht, Martin
    Rapa, Ida
    Germano, Antonina
    Sbiera, Silviu
    Daffara, Fulvia
    Sperone, Paola
    Scagliotti, Giorgio
    Allolio, Bruno
    Papotti, Mauro
    Berruti, Alfredo
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3452 - 3461
  • [36] A NOVEL GALLIUM COMPOUND DISRUPTS TUMOR IRON HOMEOSTASIS AND RETARDS THE GROWTH OF GLIOBLASTOMA IN VIVO BY INHIBITING THE IRON-DEPENDENT M2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE (RRM2)
    Chitambar, Christopher
    Al-Gizawiy, Mona
    Lozen, Andrew
    Pechman, Kimberly
    Wereley, Janine
    Wujek, Robert
    Clark, Paul
    Kuo, John
    Elford, Howard
    Hedlund, Bo
    Joshi, Devashish
    Antholine, William
    Schmainda, Kathleen
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E213 - E213
  • [37] Ribonucleotide reductase subunit 2 (RRM2) to predict shorter survival in resected stage I-III non-small cell lung cancer (NSCLC) patients.
    Rijavec, Erika
    Dal Bello, Maria Giovanna
    Savarino, Graziana
    Sini, Claudio
    Barletta, Giulia
    Genova, Carlo
    Truini, Mauro
    Pronzato, Paolo
    Merlo, Domenico Franco
    Pfeffer, Ulrich
    Grossi, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2
    Tu, Min
    Li, Haifeng
    Lv, Nan
    Xi, Chunhua
    Lu, Zipeng
    Wei, Jishu
    Chen, Jianmin
    Guo, Feng
    Jiang, Kuirong
    Song, Guoxin
    Gao, Wentao
    Miao, Yi
    MOLECULAR CANCER, 2017, 16
  • [39] Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2
    Min Tu
    Haifeng Li
    Nan Lv
    Chunhua Xi
    Zipeng Lu
    Jishu Wei
    Jianmin Chen
    Feng Guo
    Kuirong Jiang
    Guoxin Song
    Wentao Gao
    Yi Miao
    Molecular Cancer, 16
  • [40] Comprehensive bioinformatics analysis of ribonucleoside diphosphate reductase subunit M2(RRM2) gene correlates with prognosis and tumor immunotherapy in pan-cancer
    Wu, Liyuan
    Yin, Le
    Ma, Linxiang
    Yang, Jiarui
    Yang, Feiya
    Sun, Baofa
    Xing Nianzeng
    AGING-US, 2022, 14 (19): : 7890 - 7905